Breaking News

Aesica Implements Serialization Solution to Meet CFDA Changes

June 23, 2014

New requirements cut serialization deadline to three months

Aesica Pharmaceuticals S.r.l, the Italian division of Aesica, has launched a QAD integrated serialization system to comply with new requirements from China’s Food and Drug Administration (CFDA) at its site in Pianezza, which cut the serialization implementation deadline to three months from the previous 12 month timeline. In partnership with QAD, a provider of enterprise software solutions, Aesica implemented the serialization solution for two pharmaceutical products for the Chinese market.
 
The new serialization solution allows Aesica to identify individual packaging down to the smallest sellable unit sizes and individual unit serial numbers as packages are bundled, boxed and placed on shipping pallets. Aesica Pianezza can track and trace each single pack of medication and report serial numbers to the required Government Agencies for a small number of products once produced and imported.
 
Maurizio Beninati, IT manager Italy at Aesica Pharmaceuticals said, “Major changes are happening in product serialization and tracking regulations across pharmaceutical markets worldwide and China is a prime example of this. The ability to respond swiftly to adjust practices and processes to meet these challenges head on is pivotal to success in this fiercely competitive environment. QAD has proven to be a great strategic partner in the rush to meet such a hugely accelerated deadline from the CFDA. By combining our respective skills and expertise, we conquered this challenge in full.”

Related Contract Manufacturing:

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks